Advertisement

Topics

Innate Biologics, LLC Company Profile

17:52 EST 19th January 2019 | BioPortfolio

Innate Biologics, LLC is a privately held company targeting, treating and preventing inflammation and is developing a first of its kind recombinant protein platform, which specifically targets intracellular inflammatory signaling pathways. For more information, go to www.InnateBiologics.com.


News Articles [636 Associated News Articles listed on BioPortfolio]

AstraZeneca strengthens and expands oncology development and commercialisation collaboration with Innate Pharma

AstraZeneca, and its global biologics research and development arm MedImmune, announced a new multi-term agreement with Innate Pharma (Innate), building on an existing collaboration, aimed at accelera...

AstraZeneca Strengthens and Expands Oncology Development and Commercialization Collaboration with Innate Pharma

AstraZeneca, and its global biologics research and development arm MedImmune, today announced a new multi-term agreement with Innate Pharma (Innate), building on an existing collaboration, aimed at ac...

PLZF play as an indirect facilitator of thymic retention for the innate-like T-cells to aquire innate-like functions

How to trigger innate fear response?

(The Korea Advanced Institute of Science and Technology (KAIST)) There are two types of fear: learned versus innate. The latter is known to be induced without any prior experience and is thus naturall...

AstraZeneca and Innate Pharma extend oncology alliance

AstraZeneca’s MedImmune division and French biotechnology company Innate Pharma have entered into a new agreement to bolster their respective oncology...Read More... The post AstraZeneca and Inn...

AstraZeneca expands 2015 deal with Innate, gains new candidates

AstraZeneca gained rights to Innate Pharma's experimental checkpoint inhibitor drug monalizumab, currently being assessed for -More- 

AstraZeneca expands cancer immunotherapy with Innate deal

The drugmaker is buying a 9.8 percent stake in biotech company Innate Pharma, which is run by former AstraZeneca executive Mondher Mahjoubi

WuXi Biologics' Chief Quality Officer Received Foreign Post Service Award from FDA

SHANGHAI, Sept. 17, 2018 /PRNewswire/ -- WuXi Biologics (2269.HK), a leading global open-access biologics technology platform company offering end-to-end solutions for biologics discovery, development...

Drugs and Medications [7 Associated Drugs and Medications listed on BioPortfolio]

Atryn [rEVO Bioloigics, Inc.]

These highlights do not include all the information needed to use ATryn safely and effectively. See full prescribing information for ATryn. ATryn, Antithrombin (Recombinant) Lyophilized powder for rec...

Anticoagulant citrate dextrose a [Citra Labs]

ACD-A Anticoagulant Citrate Dextrose Solution, Solution A, U.S.P., PN 9350, 30 mL NDC 23731-6051-3

Rejuvesol [Citra Labs LLC]

rejuvesol red blood cell processing solution

Standardized cat pelt [Jubilant HollisterStier LLC]

ALLERGENIC EXTRACT STANDARDIZED CAT PELT AP ACETONE PRECIPITATED

Standardized cat hair [Jubilant HollisterStier LLC]

ALLERGENIC EXTRACT STANDARDIZED CAT HAIR AP Acetone Precipitated

PubMed Articles [533 Associated PubMed Articles listed on BioPortfolio]

Biologics and Small Molecule Agents in Allergic and Immunologic Skin Diseases.

Biologics and small molecules are key therapeutic options in the treatment of chronic immunologic and allergic skin conditions. By directly targeting innate and inflammatory responses within the skin,...

Considerations for implementing an informatics system to support biologics drug discovery.

A comprehensive, well-functioning and scientifically aware informatics environment is of the utmost importance in supporting effective drug discovery programs. However, implementing such a system can,...

Advanced formulations for Intranasal Delivery of Biologics.

The global biologics market has been ever increasing over the last decades and is predicted to top Euro 350 by 2020. Facing this scenario, the parenteral route of biologics administration as hitherto ...

Dose Increase beyond Labelled Dose of Biologics Is Associated With Incremental Pharmacy Costs: Results from a Real-World Study In the UK.

Evidence regarding dosing patterns of biologics among moderate to severe psoriasis patients and impact on costs in the United Kingdom (UK) is limited.

Dosing considerations for inhaled biologics.

The number of biologics in the therapeutic development pipeline is increasing including those delivered though inhalation (Morales, 2017; Fathe, 2016). Biologics comprise a broad variety of complex ma...

Clinical Trials [271 Associated Clinical Trials listed on BioPortfolio]

A Study Comparing Biologics + Methotrexate With Biologics + Tacrolimus in Patients With Rheumatoid Arthritis (RA)

The purpose of this study is to compare the efficacy of Biologics + Methotrexate with Biologics + Tacrolimus measured by the disease activity score 28 (DAS28) erythrocyte sedimentation rat...

Ustekinumab Safety and Surveillance Program Using the Ingenix NHI Database

The patients included in this observational study will be drawn from a research database containing claims and enrollment data for members of a large, geographically diverse US health plan...

Golimumab Safety and Surveillance Program Using the Ingenix NHI Database

The participants included in this observational study will be drawn from a research database containing claims and enrollment data for members of a large, geographically diverse US health ...

Real World Effectiveness of Ustekinumab in Induction and Maintenance Therapy for Crohn´s Disease

"RUN-CD" is an investigator initiated "Non interventional Trial" on biologics in Crohn´s Disease (CD) patients in Germany with a prospective documentation of effectiveness in induction an...

Tight Control Dose Reductions of Biologics in Psoriasis Patients With Low Disease Activity

Rationale/hypothesis: Moderate-to-severe psoriasis can be treated with biologics. Objective To investigate whether the dose of biologics can be reduced in patients with psoriasis with sta...

Companies [321 Associated Companies listed on BioPortfolio]

Innate Biologics, LLC

Innate Biologics, LLC is a privately held company targeting, treating and preventing inflammation and is developing a first of its kind recombinant protein platform, which specifi...

Innate Pharmaceuticals AB

Innate Pharmaceuticals' business concept is to develop bactericidal drugs that meet important medical needs and for which there is a large market. Our business is based on groundbreaking research find...

ABEC and WuXi Biologics

WuXi Biologics, a Hong Kong-listed company, is the only open-access biologics technology platform in the world offering end-to-end solutions to empower organizations to discover d...

Burst Biologics

Burst Biologics is a rapidly growing Biotechnology Company and federally registered tissue bank located in Boise, Idaho. Burst Biologics is a developer of effective tissue process...

MSD Biologics (UK) Limited

Avecia Biologics was acquired in February 2010 by MSD, the UK subsidiary of Merck & Co Inc, the world’s second largest pharmaceutical company. MSD Billingham is one of the world's leading contract ...

More Information about "Innate Biologics, LLC" on BioPortfolio

We have published hundreds of Innate Biologics, LLC news stories on BioPortfolio along with dozens of Innate Biologics, LLC Clinical Trials and PubMed Articles about Innate Biologics, LLC for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Innate Biologics, LLC Companies in our database. You can also find out about relevant Innate Biologics, LLC Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biotherapeutics
The field encompassing therapeutic materials produced using biological means, including recombinant DNA technology. Biotherapeutics, also known as biotech drugs or biologics, are therapies derived from living organisms. By harnessing these living cells...

Recombinant DNA
Recombinant DNA is the formation of a novel DNA sequence by the formation of two DNA strands. These are taken from two different organisms. These recombinant DNA molecules can be made with recombinant DNA technology. The procedure is to cut the DNA of ...


Corporate Database Quicklinks



Searches Linking to this Company Record